These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Broughton A; Cosyns JP; Jadoul M Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560 [TBL] [Abstract][Full Text] [Related]
6. [Interferon ß, nephrotic syndrome and thrombotic microangiopathy]. Quintana LF; Campistol JM Med Clin (Barc); 2015 Jan; 144(2):65-6. PubMed ID: 25458512 [No Abstract] [Full Text] [Related]
7. Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis. Mrabet S; Dahmane R; Raja B; Fradi A; Aicha NB; Sahtout W; Azzabi A; Guedri Y; Zellama D; Achour A; Sfar I; Goucha R; Abdessayed N; Mokni M Br J Clin Pharmacol; 2023 May; 89(5):1682-1685. PubMed ID: 36480744 [TBL] [Abstract][Full Text] [Related]
8. A case of malignant hypertension with thrombotic microangiopathy. Zhang J; Hu Z Intern Med J; 2018 Mar; 48(3):361-362. PubMed ID: 29512323 [No Abstract] [Full Text] [Related]
9. Favorable outcome of interferon-beta associated thrombotic microangiopathy following treatment with corticosteroids, plasma exchange and rituximab: A case report. Gerischer LM; Siebert E; Janke O; Jungehuelsing GJ; Ruprecht K Mult Scler Relat Disord; 2016 Nov; 10():63-65. PubMed ID: 27919500 [TBL] [Abstract][Full Text] [Related]
10. Malignant hypertension as a rare cause of thrombotic microangiopathy. Thind G; Kailasam K BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28596204 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature. Akita S; Fujibayashi K; Ueno EI; Wakasa M; Kawai Y; Kajinami K Intern Med; 2024 Apr; 63(8):1113-1117. PubMed ID: 37661454 [TBL] [Abstract][Full Text] [Related]